Antibody response in Crimean-Congo hemorrhagic fever

Reviews of Infectious Diseases
A J ShepherdP A Leman

Abstract

IgG and IgM antibodies became demonstrable by indirect immunofluorescence on days 7 to 9 of illness in 35 survivors of Crimean-Congo hemorrhagic fever. Maximum titers of antibody were usually attained in the second to third week of illness. Titers of IgM declined gradually thereafter and were low or negative by the fourth month. In some patients titers of IgG increased markedly between 2 and 4 months after onset of illness and remained readily demonstrable by indirect immunofluorescence 3 years after infection. Endogenous antibody response was demonstrated in only two of 15 patients who died of infection. Techniques for demonstrating antibody were (in order of decreasing sensitivity) enzyme-linked immunosorbent assay, reversed passive hemagglutination-inhibition, indirect immunofluorescence, fluorescent-focus reduction, complement-fixation, and immunodiffusion. Most patients developed relatively low levels of neutralizing antibodies (range, 1:8 to 1:32 by fluorescent-focus reduction tests), but some developed titers of 1:256 to 1:512. Plasma intended for therapeutic use should be selected on the basis of its neutralizing ability.

Citations

Aug 19, 1995·Lancet·S P Fisher-HochJ B McCormick
Jan 25, 2005·Emerging Infectious Diseases·Pierre NabethFrançois Simon
Jul 23, 2015·Laboratory Medicine·Sara ShayanSadegh Chinikar
Apr 10, 2007·The Journal of Infection·Mehmet SonmezSerdar Bedii Omay
Mar 24, 2006·The Lancet Infectious Diseases·Onder Ergönül
Nov 7, 2008·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Gul Ruhsar YilmazMehmet Ali Torunoglu
Sep 28, 2016·Proceedings of the National Academy of Sciences of the United States of America·Eleonora MelziMassimo Palmarini
Jan 31, 2006·Expert Review of Anti-infective Therapy·Zhongyu ZhuDimiter S Dimitrov
Dec 2, 2017·Nigerian Journal of Clinical Practice·Fatma AktaşZeliha Cansel Özmen
Nov 13, 2018·F1000Research·David W Hawman, Heinz Feldmann
Dec 4, 2004·Nature Medicine·Thomas W Geisbert, Peter B Jahrling
May 23, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mark R WallaceKenneth C Hyams
Feb 20, 2010·Scandinavian Journal of Infectious Diseases·Cigdem Ataman HatipogluAli Pekcan Demiroz
Jul 12, 2019·Journal of Virology·David W HawmanHeinz Feldmann
Aug 11, 2000·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·J P Chen, T M Cosgriff
Feb 7, 2020·Journal of Clinical Microbiology·Vanessa N Raabe
Mar 10, 2015·Expert Review of Anti-infective Therapy·Hasan Tezer, Meltem Polat
Dec 1, 1994·Epidemiology and Infection·F J BurtR Swanepoel
Dec 21, 2017·PLoS Neglected Tropical Diseases·Dominique GoedhalsFelicity J Burt
May 6, 2019·Expert Review of Molecular Diagnostics·Anna Papa
Mar 19, 2020·Emerging Infectious Diseases·Daniel OluwayeluOyewale Tomori
May 29, 2020·BioResearch Open Access·Thomas Tipih, Felicity Jane Burt
Aug 5, 2017·Virology Journal·Hajer M SulimanImadeldin E Aradaib
Mar 23, 2021·Current Tropical Medicine Reports·Paul A KuehnertKeersten M Ricks
Sep 7, 2020·Travel Medicine and Infectious Disease·Enrica SerretielloMassimiliano Galdiero

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Argentine Hemorrhagic Fever

Argentine hemorrhagic fever (AHF) is an endemo-epidemic disease caused by junín virus (JUNV), a member of the arenaviridae family. Discover the latest research on AHF here.